Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay).
about
Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Using the Modified Magee Equat ...... ore Assay (Oncotype DX Assay).
@en
Using the Modified Magee Equat ...... 21-Gene Recurrence Score Assay
@nl
type
label
Using the Modified Magee Equat ...... ore Assay (Oncotype DX Assay).
@en
Using the Modified Magee Equat ...... 21-Gene Recurrence Score Assay
@nl
prefLabel
Using the Modified Magee Equat ...... ore Assay (Oncotype DX Assay).
@en
Using the Modified Magee Equat ...... 21-Gene Recurrence Score Assay
@nl
P2093
P2860
P356
P1476
Using the Modified Magee Equat ...... ore Assay (Oncotype DX Assay).
@en
P2093
Debra L Zynger
Gary Tozbikian
Yanjun Hou
P2860
P304
P356
10.1093/AJCP/AQX008
P407
P577
2017-04-25T00:00:00Z